These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 19614764

  • 1. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
    Cooper WA, Kohonen-Corish MR, McCaughan B, Kennedy C, Sutherland RL, Lee CS.
    Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
    [Abstract] [Full Text] [Related]

  • 2. Clinical implication of cyclin B1 in non-small cell lung cancer.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Kimura Y, Uchida Y.
    Oncol Rep; 2003 Jul; 10(5):1381-6. PubMed ID: 12883711
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
    Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L.
    Cancer Res; 2000 Aug 01; 60(15):4000-4. PubMed ID: 10945597
    [Abstract] [Full Text] [Related]

  • 4. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY, Liao ZS, Jiang SP, Zhang W, Li JG, Zheng DH.
    Ai Zheng; 2003 Jan 01; 22(1):86-90. PubMed ID: 12561444
    [Abstract] [Full Text] [Related]

  • 5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 6. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
    Kosacka M, Piesiak P, Porebska I, Korzeniewska A, Jankowska R.
    Pol Merkur Lekarski; 2011 Apr 15; 30(178):253-8. PubMed ID: 21595169
    [Abstract] [Full Text] [Related]

  • 7. [The evaluation of prognostic value of cyclin B1 expression in patients with resected non-small-cell lung cancer stage I-IIIA--preliminary report].
    Kosacka M, Korzeniewska A, Jankowska R.
    Pol Merkur Lekarski; 2010 Feb 15; 28(164):117-21. PubMed ID: 20369739
    [Abstract] [Full Text] [Related]

  • 8. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
    Kosacka M, Piesiak P, Porebska I, Korzeniewska A, Dyla T, Jankowska R.
    In Vivo; 2009 Feb 15; 23(4):519-25. PubMed ID: 19567385
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 15; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y.
    J Clin Oncol; 2004 Oct 15; 22(20):4165-73. PubMed ID: 15483027
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
    Yuan K, Qian C, Zheng R.
    Med Sci Monit; 2009 Nov 15; 15(11):BR313-9. PubMed ID: 19865048
    [Abstract] [Full Text] [Related]

  • 14. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 15; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 15. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.
    Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM.
    Lung Cancer; 2007 Nov 15; 58(2):267-74. PubMed ID: 17673327
    [Abstract] [Full Text] [Related]

  • 16. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun 15; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W.
    Cancer; 2002 Jun 01; 94(11):2874-81. PubMed ID: 12115375
    [Abstract] [Full Text] [Related]

  • 18. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH, Wang C, Zhang YH, Yang YH, Zhan HY, Zhang LM.
    Zhonghua Yi Xue Za Zhi; 2007 Dec 04; 87(45):3228-32. PubMed ID: 18399120
    [Abstract] [Full Text] [Related]

  • 19. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Obermann EC, Went P, Pehrs AC, Tzankov A, Wild PJ, Pileri S, Hofstaedter F, Dirnhofer S.
    Oncol Rep; 2005 Dec 04; 14(6):1461-7. PubMed ID: 16273239
    [Abstract] [Full Text] [Related]

  • 20. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May 04; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.